EP0133321A1

EP0133321A1 - DNA gene, process for production thereof and plasmid containing the same

Info

Publication number: EP0133321A1
Application number: EP19840109016
Authority: EP
Inventors: Tetsuo Miyaka; Takanori Oka; Gakuzo Tamura; Koji Yoda; Yasuhiro Kikuchi; Makari Yamasaki
Original assignee: Wakunaga Pharmaceutical Co Ltd
Current assignee: Wakunaga Pharmaceutical Co Ltd
Priority date: 1983-08-01
Filing date: 1984-07-30
Publication date: 1985-02-20
Also published as: DE3485923D1; JPS6030687A; EP0133321B1; DE3485923T2

Abstract

A DNA (i) gene comprising a DNA (ii) portion corresponding to the gene coding for a signal peptide, said DNA (ii) portion having one restriction endonuclease recognition site artificially created with at least one base pair of said DNA (ii) as at least a part of the members constituting said recognition site is disclosed. Also disclosed is a method of production of the DNA in which one restriction endonuclease recognition site is artificially created by modifying the base sequence of the DNA (ii) portion without changing the amino acid sequence corresponding to the base sequence in utilization of degeneracy of codons. Plasmid comprising the DNA (ii) portion corresponding to the gene coding for the signal peptide derive from the alkaline phosphatase is also disclosed.

Description

BACKGROUND OF THE INVENTION

Technical field

This invention relates to utilization of a DNA gene participating in secretion of an exogenous or foreign gene product. More specifically, the present invention pertains to a DNA (i) gene which comprises a DNA (ii) portion corresponding to the gene coding for a peptide for excreting the protein produced, as the expression of the DNA (i) gene, within cells of a host microorganism through the membrane, which peptide will hereinafter be referred to as "signal peptide", which DNA (ii) portion is so processed that an exogenous gene can be linked directly to the DNA (ii) gene. It also relates to a process for producing the DNA gene and also to a plasmid containing the DNA gene portion.

Prior art

Techniques for producing a large amount of a desired gene product by the use of recombinant DNA technology are now being established, as evidenced by the large number of related reports and published patent specifications. With the establishment of these techniques, genetic analyses have also been made, and the knowledge that a series of peptides comprising 15 to 30 amino acids participate in secretion of an expressed protein out of the cell of a host has also been gained from among such analyses.
The knowledge concerning secretion of the expressed protein out of cells is called "Signal Hypothesis" [J. Cell Biol., 67, 835 (1975)], and the experimental results in support of this hypothesis are being accumulated [Secretory Mechanisms, 9,Cambridge University Press, Cambridge (1979); Seikagaku (Journal of Biochemistry), 52, 141 (1980), etc.]. The outline of the signal peptide and its function are described in, for example, Japanese Laid-open Patent Publication No.69897/1983, and the signal peptide is also recognized as participating in the permeation of proteins through membranes.
At present, various inventions utilizing signal peptides are disclosed in Laid-open or Published Patent Publications (e.g., Japanese Laid-open Patent Publications Nos. 19092/1980, 45395/1980, 137896/1981, 145221/1981 and 154999/1981). According to any of the processes disclosed in these publications, the structural gene coding for the protein to be secreted by a host microorganism is cleaved at a suitable restriction endonuclease recognition site, and an exogenous gene is connected thereto through a linker for matching to the frame. As a result, the exogenous protein upon expression of such a fused gene has at its N-terminus side a superfluous peptide attached. Accordingly, there is a possibility that such a superfluous peptide might inhibit secretion or have a deleterious effect on the biological activity of exogenous protein.
Thus, the techniques of the prior art utilizing signal peptides involve various problems and it would be desirable to solve these problems.

SUMMARY OF THE INVENTION

It is an object of the present invention to overcome the above described problems, and it is intended to accomplish this object by designing and utilizing a DNA gene which will make possible linking of a gene coding for an exogenous protein to the gene coding for a signal peptide immediately thereafter.
Accordingly, the DNA gene comprising a DNA portion corresponding to a gene coding for a signal peptide according to the present invention comprises a DNA (ii) portion corresponding to the gene coding for a signal peptide, the DNA possessing one restriction endonuclease recognition site artificially created with at least one base pair of the DNA as at least a part of the members constituting the recognition site.
A process for producing a DNA (i) gene comprising a DNA portion corresponding to the gene coding for a signal peptide according to the present invention comprises the steps of:

(a) providing a DNA gene comprising the DNA (ii) portion corresponding to the gene coding for the signal peptide; and
(b) modifying the base sequence of the DNA (ii) portion without changing the amino acid sequence corresponding to the base sequence, thereby creating a restriction endonuclease recognition site containing, as at least a part thereof, at least one base pair of the DNA (ii) corresponding to the gene coding for the signal peptide.

Another process for producing a DNA (i) gene comprising a DNA portion corresponding to the gene coding for a signal peptide according to the present invention comprises the steps of:

(a) providing a DNA gene comprising a DNA (ii) portion corresponding to the gene coding for the signal peptide;
(b) modifying the base sequence of the DNA (ii) portion without changing the amino acid sequence corresponding to the base sequence, thereby creating a restriction endonuclease recognition site containing, as at least a part thereof, at least one base pair of the DNA corresponding to the gene coding for the signal peptide;
(c) effecting cleavage at the restriction endonuclease cleavage site within the restriction endonuclease cleavage recognition site by the restriction endonuclease, thereby producing a DNA (iv) fragment comprising a moiety upstream to the cleavage site of the DNA (ii) corresponding to the gene coding for the signal peptide and having a cleaved end of the restriction endonuclease;
(d) providing a DNA fragment comprising a DNA (iii) which can exist downstream from the restriction endonuclease cleavage site of the DNA (ii) portion corresponding to the gene coding for the signal peptide and a DNA (v) corresponding to the gene coding for an exogenous protein existing directly downstream from the DNA (iii) which can exist and having the restriction endonuclease cleaved end on the upstream terminus; and
(e) linking the DNA fragment from the above step (a) and the DNA fragment from the above step (d) to each other.at the restriction endonuclease cleaved ends, thereby obtaining a DNA (i) gene comprising the DNA (ii) portion corresponding to the gene coding for the signal peptide and the DNA (v) portion corresponding to the gene coding for the exogenous protein directly linked to the downstream terminus of the DNA (ii) portion.

The plasmid according to the present invention comprises a DNA portion corresponding to the controlling region derived from an alkaline phosphatase and a DNA (ii) portion corresponding to the gene coding for the signal peptide derived from the alkaline phosphatase, the DNA (ii) portion corresponding to the gene coding for the signal peptide being defined as follows.

. (a) The DNA portion has a restriction endonuclease recognition site artificially created containing, as at least a part of the recognition site, at least one base pair thereof; and
(b) the restriction endonuclease cleavage site within the restriction endonuclease recognition site exists at the boundary between the DNA (ii) portion corresponding to the gene coding for the signal peptide and the DNA (v) portion which can exist linked directly to the downstream terminus of the DNA (ii) portion.

Thus, in order to afford extracellular excretion of proteins from exogenous gene by a signal peptide, the present invention has a specific feature in that a restriction endonuclease recognition/cleavage site is created for incorporation of an exogenous gene into the signal peptide gene, and the creation of this site is based on skillful utilization of the fact that there is degeneracy in codons comprising DNA base pairs.
When cleavage is effected at the created restriction endonuclease recognition/cleavage site by the restriction endonuclease concerned, and in the case where the cleavage site exists contiguous to the downstream terminus of the signal peptide gene DNA, it follows that an exogenous gene having at its upstream terminus a DNA fraction complementary to said restriction endonuclease cleaved end formed is prepared and is linked at the cleaved end to the signal peptide gene, whereby the exogenous gene will be linked directly to the downstream terminus of the signal peptide gene. In the case where the cleavage site of the signal peptide gene is located not at its downstream terminus but upstream to its downstream terminus and cleavage thus takes place at a place upstream to the downstream terminus of the signal peptide gene resulting in disintegration of the signal peptide gene, a DNA fragment comprises a DNA (p) for an exogenous gene and a DNA (q) linked to the upsteam terminus of the DNA (p) gene, which DNA (q) corresponds to the DNA portion of the DNA for the signal peptide gene downstream from the cleavage site, and the D_NA fragment is then linked to the cleaved end of the signal peptide gene, whereby the signal peptide gene once disintegrated by the cleaving will be restored for both strands of DNA simultaneously with realization of a structure wherein the exogenous gene is linked directly to the downstream end of the signal peptide.
The DNA gene we have produced can thus circumvent the above problems when it is utilized as a vector incorporated in a suitable plasmid or phage and has the following advantages when incorporated into a host microorganism for production of a desired protein.

(a) Purification of the expression products formed is easy. In the prior art, the entire host cell was crushed at an appropriate stage after growth of the host microbe, and useful substances were purified by extraction from among various cell contents of the microbe used. Accordingly, an enormous amount of labor was necessary, and also purification was sometimes difficult depending on the substance being purified. By the use of a vector utilizing the DNA gene of the present invention, the protein produced is excreted out of the microorganism cells, and it is thus easy to identify and recover the desired substance secreted from the medium since the constituents of the growth medium for the microorganism are known.
(b) The substance produced can be protected from decomposition by peptidase. More specifically, because of the presence of much peptidase (protease) within the microbial cells, unnecessary proteins are subject to rapid hydrolysis, but immediate excretion of the desired useful protein out of microbial cells without undue retention therein will lead to protection of the desired protein from the above hydrolase.
(c) Any exogenous protein can be expressed. For example, according to the fused protein method of the prior art, such a typical method for obtaining the desired protein out of the fused protein by cleaving the fused protein at the site where the desired protein is fused with an undesired protein as treatment of the fused protein with cyanogen bromide which is specific to methionine or as tripsin digestion of the fused protein, tripsin being specific to lysine or arginine, is applicable only to proteins which do not contain methionine, lysine or arginine. On the other hand, when producing a protein according to the direct expression method [Nature 281, 544 (1979)], an initiation codon (methyonine) is required to exist at the N-terminus of the gene, and some proteins produced are obtained with methyonine being attached at the N-terminus (see Japanese Laid-open Patent Publication No. 68399/1981). Because it is technically difficult to remove by decomposition such methyonine at the terminus by cyanogen bromide treatment, the protein produced having the methionine is consequently different in nature from the natural product. In contrast, when the exogenous gene is expressed in a host microbe with the use as a vector of the DNA gene according to the present invention, the proteins produced once as fused or hybrid protein with a signal peptide are cleaved specifically at the signal peptidase portion to provide a mature protein with a desired composition secreted out of the host microorganism cells.

BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:

FIG. 1 is a diagram of the vicinity of the linked site between the signal peptide (1) and the structural gene (3), indicating the restriction endonuclease recognition site (2), the restriction cleavage site (broken line), and the signal peptide cleavage point (4);
_FIG. 2 is a flow chart for the production of the plasmid pTA 529 of the present invention;
FIGS. 3A and 3B are facsimiles of autoradiograms obtained when colony hybridization was carried out;
FIG. 4 is a diagram indicating the result of agarose gel electrophoresis; and
FIG. 5 is a facsimile of an autoradiogram obtained when the base sequence was determined according to the Maxam-Gilbert method.

DETAILED DESCRIPTION OF THE INVENTION

DNA gene

The gene comprising the DNA portion corresponding to the gene coding for signal peptide according to the present invention (in the present specification, particularly in the description hereinafter, "DNA corresponding to the gene coding for signal peptide" is referred to as "signal peptide gene DNA") has one restriction endonuclease recognition site artifically created in the DNA, as mentioned above. And, the restriction endonuclease recognition site contains at least one base pair of the DNA as at least a part thereof.
An example of the DNA gene according to the present invention thus defined is as shown in FIG. l. This embodiment comprises the signal peptide gene DNA portion (1) and the DNA portion (2) linked thereto on its downstream side terminus. The "DNA gene containing the DNA portion corresponding to the gene coding for signal peptide" as mentioned herein may comprise at least the DNA portion (I). In the present invention, the term "downstream" when it is concerned with DNA means the direction to the right or location at the right when the 5' → 3' chain (⊕ chain) is shown above and the 3' ← 5' chain (⊖ chain) is shown below. The term "upstream" will then be self-explanatory.
FIG. 1 shows a part of the DNA gene comprising a double-stranded DNA, in which A, G, C and T stand for adenine, guanine, cytosine and thymine, respectively, and Lys, Ala and Trp lysine, alanine and tryptophane, respectively. The region (1) of the double-stranded DNA corresponds to.the signal peptide gene DNA portion, the region (3) to the recognition site of the restriction endonuclease Hind III, and the broken line to the Hind III cleavage site. The region (2) corresponds to the DNA portion linked to the signal peptide immediately thereafter on its downstream side.
According to a preferred embodiment of the present invention, the signal peptide gene DNA is one which has originated from an alkaline phosphatase. This DNA has a codon of GCC for the alanine at its downstream terminus.
The DNA gene shown in FIG. 1, therefore, corresponds to one obtained by modifying the codon GCC at the downstream terminus of the DNA portion (1) from alkaline phosphatase to GCT and further the subsequent base C to T. Since there is degeneracy in the codon for alanine, GCT after modification is also the codon for alanine, and therefore the DNA portion (1) in FIG. 1 is still a DNA corresponding to the gene coding for the signal peptide from alkaline phosphatase.
The signal peptide gene DNA from alkaline phosphatase has, just upstream to the codon for alanine at its downstream terminus, a codon AAA for lysine, which codon for alanine is accompanied by, just downstream from it, a codon CGG for arginine.
Accordingly, upon modification into GCT of the codon GCC for alanine at the downstream terminus of the signal peptide gene DNA from alkaline phosphatase and modification into T of the base C subsequent to the alanine, a recognition site (3) AAGCTT for the restriction endonuclease Hind III is created, namely from the base pair at the downstream terminus of the signal peptide gene DNA, 4 base pairs upstream thereto and one base pair downstream therefrom. Thus, there is created in the signal peptide gene DNA a restriction endonuclease recognition site containing at least the base pair at said terminus as at least a part of its constituting members.
In the embodiment of the invention shown in FIG. 1, the cleavage site within the recognition site (3) of Hind III is as shown by the broken line, and its position exists between the signal peptide gene DNA and the DNA portion which is to be linked thereto immediately thereafter on its downstream side (the region (2) already linked in FIG. 1) (the position of the cleavage site means that on the downstream side of the double-stranded DNA). It is most preferable in the present invention that the restriction endonuclease cleavage site exist at such a position. This is because of the following reason. The cleavage-site is utilized to link an exogenous gene (DNA corresponding thereto) directly to the gene coding for the signal peptide (DNA corresponding thereto), while the fused or hybrid protein formed by expression of the hybrid gene is cleaved by the signal peptidase at a position between the signal peptide and the protein subsequent thereto. Therefore, if the restriction endonuclease cleavage site is thus coincident with the signal peptidase cleavage site, and in the case of the embodiment of the invention shown in FIG. 1, only supplementing AGCT to the 5'-side of the (D chain of the exogenous gene (in this embodiment, beginning with the codon TGG for Trp), is required for making it possible to link the exogenous gene to the cohesive end of the signal peptide gene after digestion with Hind III. In this connection, if one is not reluctant to supplement bases to the 3'-side of the ⊖ chain of the exogenous gene, the restriction endonuclease cleavage site can exist on the upstream side, of course, and existence of such a cleavage site is also included within the scope of the present invention.
The "DNA corresponding to the gene coding for the signal peptide", which is the important component in the DNA gene of the present invention, may have a variety of base sequences depending on the signal peptide employed. Specific examples of signal peptide are that of β-lactamase [Proc. Natl. Acad. Sci. U.S.A., 75, 3737 (1978)], that of lipoprotein [ibid, 74, 1004 (1977)], and that of alkaline phosphatase [Eur. J. Biochem., 96, 49 (1979)]. Concerning signal peptides, reference may be made to "Tampakushitsu'Kakusan.Koso" (Protein, Nucleic Acid and Enzyme), extra edition ("Genetic Manipulation"), vol. 26, No.4, pages 386-394. In the present invention, these signal peptides originating from natural products as well as DNA's synthesized according to the base sequences thereof can be used (the former being preferred).
The signal peptide gene DNA preferably used in the present invention is one having the base sequence of alkaline phosphatase, particularly one which originates from alkaline phosphatase. This is because the advantages as described with reference to FIG. 1 can be obtained.
In one embodiment of the DNA gene of the present invention as shown in FIG. 1, which has been prepared, as described in detail below, by modification of the DNA from alkaline phosphatase, the DNA portion (2) from alkaline phosphatase is linked to the signal peptide gene DNA portion (1) immediately after its downstream terminus. Another embodiment of the DNA gene according to the present invention is one wherein the DNA portion (2) is the DNA portion corresponding to the gene coding for the exogenous protein. To abide by the purpose for introducing the restriction endonuclease cleavage site, the embodiment in which the DNA portion (2) originates from an exogenous gene may be said to be a specific example conforming to the purport of the invention.
An example of the DNA gene of the present invention encompassed within the category of the latter embodiment thereof comprises the signal peptide gene DNA portion, constituted by the moiety from a natural product and a moiety which is synthesized. More specifically, the moiety upstream to the restriction endonuclease cleavage site included is one from a natural product, while the moiety downstream from the cleavage site is one synthesized. The synthesized moiety downstream from the cleavage site in the example shown in FIG. 1 is the four base (AGCT) of the ⊕ chain, but a synthesized moiety is required also in the 0 chain, if the cleavage site exists upstream to that position shown.

Production of DNA gene

The process for production of the DNA (i) gene comprising the signal peptide gene DNA comprises the steps of:

(a) providing a DNA gene comprising a DNA (ii) portion corresponding to the gene coding for the signal peptide;
(b) modifying the base sequence of the DNA (ii) portion without changing the amino acid sequence corresponding to that base sequence, thereby creating a restriction endonuclease recognition site containing, as at least a part thereof, at least one base pair of the DNA (ii) corresponding to the gene coding for the signal peptide.

The process for producing the DNA gene according to the present invention may alternatively be comprehended as a method of modifying a given DNA gene.
As described above, the DNA gene conforming to the purport of the present invention has a DNA portion originating from an exogenous gene present immediately after the downstream terminus of the signal peptide gene. Such a DNA gene can be produced by practicing the steps (c) to (e) set forth below for the DNA gene as prepared above:

(c) effecting cleavage at the restriction endonuclease cleavage site within the restriction endonuclease cleavage recognition site created by the restriction endonuclease, thereby producing a DNA fragment comprising a moiety of the DNA corresponding to the gene coding for the signal peptide upstream to the cleavage site and having a cleaved end of the restriction endonuclease;
(d) providing a DNA fragment which comprises a DNA (iii) which can exist on the downstream side of the restriction endonuclease cleavage site of the DNA (ii) portion corresponding to the gene coding for the signal peptide and a DNA (v) corresponding to the gene coding for an exogenous protein directly downstream from the DNA (iii) which can exist, and having the restriction endonuclease cleaved end at its upstream terminus; and
(e) linking the DNA fragment from the above step (c) and the DNA fragment from the above step (d) to each other at the restriction endonuclease cleaved ends, thereby obtaining a DNA gene comprising the DNA portion corresponding to the gene coding for the signal peptide and the DNA portion corresponding to the gene coding for the exogenous protein directly linked to the downstream terminus of the DNA fragment (c).

The "DNA (iii) which can exist on the downstream side of the restriction endonuclease cleavage site of the DNA (ii) portion corresponding to the gene coding for the signal peptide" is not essential in that it is not required when the cleavage site is at the downstream terminus of the DNA (ii) but is required when the cleavage site is located upstream to the downstream terminus of the DNA (ii) and there is thus a DNA portion between the cleavage site and the downstream terminus of the DNA (ii), which DNA portion is cleaved off when cleavage is performed and is thus required for restoring the once disintegrated DNA (ii) when linking of the exogenous gene is performed.
For creation of a restriction endonuclease recognition site by modification of at least one base pair of the signal peptide gene DNA, and, if required, the gene DNA downstream from the signal peptide, any method suited for the purpose may be employed.
As the method for modification of base sequence, a method such as the point mutation method employing a synthetic fragment, the method employing a mutation inducer (X-ray, N-methyl-N'-nitro-N-nitrosoguanidine, etc.), the method in which mutation is caused by use of sulfite ions or nitrite ions, or the method through replacement with a synthesized gene may be considered. However, as a method which is simple and reliable in obtaining a desired DNA gene, it is preferable to use the point mutation method employing a synthetic fragment [Science, 29, 19, September (1980)].
The essential point in the modification of the base sequence is to create a restriction endonuclease recognition site without changing the amino acid sequence within a given signal peptide. The restriction endonuclease recognition site, which is within the gene coding for the signal peptide, should preferably be as close as possible to the cleavage point of the signal peptide by signal peptidase, more preferably its cleavage site being coincident with the cleavage point of the signal peptide, as described above. According to the most preferred embodiment, as shown in FIG. 1, the codon GCC at the downstream terminus of the base sequence (1) coding for the signal peptide of alkaline phosphatase is modified into GCT, whereby the amino acid sequence is not changed by this modification since GCC and GCT are both coding for alanine, and, further, the base C just downstream from the gene (1) for the signal peptide is modified into T to create the restriction endonuclease Hind III recognition site. In this case, the cleavage point(shown by the arrowhead (4)) and the restriction endonuclease cleavage site (broken line) coincide with each other. Accordingly, linking of a desired exogenous structural gene to the signal peptide immediately thereafter is rendered possible. In this case, the restriction endonuclease cleaved end is a cohesive end. By providing a desired exogenous gene with a cohesive end of AGCT at its upstream terminus, it is possible to obtain a fused protein in which the signal peptide and the exogenous protein are linked directly together to accomplish the above object, as described above.

Utilization of DNA gene

The DNA gene of the present invention can be utilized as a vector in such a form that a desired exogenous structural gene is linked to the DNA gene and that, when necessary, it is inserted into a plasmid or a phage at an appropriate position downstream to its promoter. By introducing an exogenous gene incorporated in the vector into a host microorganism such as E. coli, and culturing the host microorganism, the protein formed by expression of the exogenous gene would be excreted by the action of the signal peptide out of the microorganism cells. Such utilization of the gene DNA according to the present invention can be appropriately practiced, of course, by referring to the textbooks or literature concerning recombinant DNA technology.
A typical mode of utilization of the DNA gene according to the present invention is that as a plasmid to be used as the vector. Such a plasmid comprises a DNA portion corresponding to the controlling region from alkaline phosphatase and a signal peptide gene DNA (ii) portion from alkaline phosphatase under control of the region, the signal peptide gene DNA (ii) being defined as follows:

(a) the DNA (ii) portion has a restriction endonuclease recognition site artificially created and containing, as at least a part of said recognition site, at least one base pair thereof; and
(b) the restriction endonuclease cleavage site within said restriction endonuclease recognition site exists at the boundary between the DNA (ii) portion corresponding to the gene coding for the signal peptide and a DNA (iv) portion which is to exist linked directly to the downstream terminus of the DNA (ii) portion.

Thus, the plasmid has the preferred DNA gene of the present invention as described above incorporated into a plasmid having a controlling region of alkaline phosphatase so as to place the gene under control of the region, thereby enabling proliferation within the host microorganism.
A specific example of this plasmid has the codon (x) at the downstream terminus of the DNA (ii) portion corresponding to the gene coding for the signal peptide of the plasmid pYK [this plasmid is deposited as E. coli K12c600 containing this plasmid, namely E. coli K12c600 (pYK 283), Fermentation Research Institute, Agency of Industrial Science & Technology, Japan (FERM-P 7072)] and the initial codon (y) of the DNA portion linked thereto downstream from the codon (x), which codons (x and y) are as shown in FIG. 1. The bacteriological properties of E. coli K12c600 (pYK 283) are the same as those of the host microorganism E. coli K12c600 except for those originating from the plasmid pYK 283 contained therein, and some of its specific properties are described in the document annexed to the sample of the microorganism deposited at Fermentation Research Institute, Agency of Industrial Science & Technology.
The plasmid pTA 529 can be produced according to the process as shown in FIG. 2. It should be understood, however, that there are other processes than that shown in FIG. 2, and the plasmids incorporating other DNA genes of the present invention can also be produced similarly.
Now, referring to FIG. 2, the plasmid pYK 283 (①) is subjected to the restriction endonuclease EcoRI treatment in the presence of ethidium bromide (EtBr) to form a nicked DNA ②, which is a double-stranded cyclic DNA having a nick on one strand, and the nicked plasmid ② is then subjected to the exonuclease III digestion to form a single stranded DNA (CD). The single-stranded DNA thus obtained is then processed into a hetero-duplex DNA 0 through the action thereto of DNA polymerase I with a use as a primer ④ of a synthetic oligonucleotide for inducing point mutation previously synthesized into a double stranded DNA, which is then converted into the hetero-duplex DNA @ upon the action of DNA ligase (T4 DNA ligase). Then, the hetero-duplex is introduced into E. coli K 12c600, following the method of Kuschner (Genetic Engineering, 1978; 17 (1978)) to transform the-host, and strains which have become ampicillin resistant are obtained (⑥).
From among these strains, the desired mutant strain is obtained upon colony hybridization (Methods in Enzymology, 68, 379, Academic Press INc., New York, 1979). Finally, the plasmid is taken out of this strain, and it is confirmed according to the Maxam-Gilbert method (Methods in Enzymology, Vol. 65, Nucleic Acid Part I, 499 - 560 (1980), Academic Press) whether or not the desired sequence is formed to obtain the plasmid pTA 529.
As to the details concerning the preparation of the plasmid, reference is made to the experimental examples as shown below. As the method for synthesis of the oligonucleotide as the primer referred to hereinabove, reference may be made to the diester method (Science, 203, 614 (1979)), the triester method (Nucleic Acids Research 8, 2331 (1980), ibid 8, 5193 (1980), ibid 8, 5491 (1980)), or the solid phase method (Nature, 281, 18 (1979), Biochemistry 1980, 6096 (1980)), the liquid phase method or the method employing an enzyme (Nucleic Acids Research, 8, 5753 (1980)), etc. In the case of the present invention, the solid phase method is preferred.

Experimentation

(1) Synthesis of oligonucleotide

As an oligonucleotide for inducing point mutation, a fragment having the following base sequence was synthesized:
GA - CA - AAA - GC - TT - GG - GG - AA - TT - C --
wherein G represents guanine, A adenine, C cytosine, T thymine and
polystyrene.
With the use of 30 mg of a 1% polystyrene resin to which cytosine had been bonded, a 3'-terminal diester type nucleotide (20 mg of a monomer, 25 mg of a dimer and 35 mg of a trimer), and 20 mg of a condensing agent mesitylene sulfonyl triazolide (hereinafter referred to as MSNT), condensation was successively repeated to obtain a desired chain length according to the method of Nucleic Acid Research,8, 5491 (1980). The overall condensation yield was found to be 35%. After completion of the final condensation step, the resin was dried and 300 µl of a solution of 0.5 M picolinealdoxime-tetramethylguanidine in pyridine- water (9:1) was added threto, and the mixture was left to stand overnight at 37°C. Then, conc. ammonia water (4 ml) was added, and after the mixture was left to stand overnight at 55°C, the resin was removed by filtration. The filtrate was dissolved in water and subjected to extraction with ether (deprotection). Subsequently, the ether extract was subjected to gel filtration with Sephadex® G-50 (eluent: 50 mM triethylammonium bicarbonate, pH 7.5). During the gel filtration, the respective fractions were subjected to measurement of absorption at 260 nm, and the peak eluted first was collected and subjected to high performance liquid chromatography (HPLC), followed by reaction in 2 ml of 8% acetic acid at room temperature for 10 minutes for conversion into a 5'-hydroxyl derivative to obtain the desired synthetic segment. As the column, p Bondapak C 18 (reverse phase) was employed. The base sequence of the oligonucleotide synthesized was confirmed according to the Maxam-Gilbert method.
As the next step, 300 pmol of the fragment synthesized was freeze-dried and allowed to react with 1.5 µl of polynucleotide kinase (15 units) in 20 µl of a solution of 50 mM Tris-hydrochloride buffer (pH 7.5), 10 mM magnesium chloride, 5 mM DTT (dithiothreitol) and 1.25 mM ATP at 37°C for 2 hours (phosphorylation), which step was followed by boiling at 90°C for 2 minutes to terminate the phosphorylation reaction. Then, the reaction mixture was desalted with Sephadex® G-50 to obtain the desired oligomer.

(2) Induction of point mutation

The pYK 283 (plasmid) (10 µg) was dissolved in 100 µl of a solution of 100 mM Tris-hydrochloride buffer (p_H 7.5), 7 mM magnesium chloride, 50 mM sodium chloride, 7 mM mercaptoethanol, 120 µg/ml ethidium bromide and 0.01% Nonidet (registered trade mark) P-40, and 2 µl of EcoRI (10,000 U/1.67 ml) was added thereto to carry out reaction at 37°C for one hour. After removal of the proteins by addition of phenol-chloroform (1:1), ethanol precipitation was conducted. The precipitate was dissolved in 50 µl of a solution of 10 mM Tris-hydrochloride buffer (pH 7.5), 7 mM magnesium chloride, 100 mM sodium chloride, 7 mM mercaptoethanol and allowed to react with 1.5 µl of Exonuclease III (5000 U/107 µl) at 37°C for one hour.
After completion of the reaction, 1.5 µl of Hinf I (5000 U/883 µl) and 1 µl of bacterial alkaline phosphatase (BAP) (10,000 U/39 µl) were added to the solution to carry out reaction for one hour, and, after removal of the proteins by addition of phenol-chloroform (1:1), ethanol precipitation was conducted. To the precipitate were added 3 µl of E. coli DNA polymerase I larger fragment (200 U/134 µl) and 3 µl of T4 DNA ligase (200 U/80 µl) in a solution of 60 pmol of the oligonucleotide phosphorylated at the 5'-terminus with 2 µl of polynucleotide kinase (200 U/20 µl) as synthesized above, 20 mM Tris-hydrochloride buffer (pH 7.5), 10 mM magnesium chloride, 10 mM DTT, 750 µM each of dATP, dGTP, dCTP and TTP, and 1 mM ATP, and the reaction was carried out overnight at 14°C. After removal of the proteins with addition of phenol-chloroform (1:1), ethanol precipitation was conducted to obtain a closed circular DNA.

(3) Transformation

By use of the above DNA in an amount equivalent to about 2 µg as the DNA amount of the pYK 283, transformation of E. coli K12c600 was performed according to the method of Kuschner. More specifically, after the E. coli K12c600-strain was cultured in 2 ml of L-medium to 0.3 - 0.4 OD/550 nm, the microbes were collected and suspended under ice-cooling in 1 ml of a solution of 10-mM MOPS (3-[N-morpholino]propanesulfonic acid) (pH 7.0), 10 mM rubidium chloride, which step was followed immediately by collection of the microbes. Subsequently, the microbes were suspended in 1 ml of a solution of 100 mM MOPS (pH 6.5), 10 mM rubidium chloride, 50 mM calcium chloride and left to stand in an ice-bath for 30 minutes.
Again, after the microbes had been collected, they were suspended in 0.2 ml of a solution of 100 mM MOPS (pH 6.5), 10 mM rubidium chloride, 50 mM calcium chloride, and 3 µl of DMSO (dimethyl sulfoxide) and DNA (the reaction mixture after induction of point mutation, recovered by ethanol precipitation) were added thereto, and the mixture was further left to stand in an ice-bath for 30 minutes. Then, after heating at 45°C for one minute, 2 ml of L-medium was added, and the mixture was left to stand at room temperature for one hour. Thereafter 1200 strains which became ampicillin resistant were obtained on an L-plate (1% trypton, 0.5% yeast extract, 0.5% sodium chloride, 1.5% agar) containing ampicillin.

(4) Cloning of mutant strain

Cloning was conducted by colony hybridization. More specifically, 550 strains of the above 1200 ampicillin resistant strains were transferred to a nitrocellulose filter, cultured overnight on L-plate, then transferred to an L-plate containing Spectinomycin (300 pg/ml), and further cultured overnight. The filter was immersed in 0.5N sodium hydroxide for 15 minutes and washed twice with 0.5 M Tris-hydrochloride buffer (pH 7.5), 1.5 M sodium chloride. Then, after washing with 0.03 M sodium-citrate, 0.3 M sodium chloride, the filter was dried at 60°C for one hour, and further dried in a vacuum oven at 80°C for 2 hours. The filter was immersed overnight at 37°C in a solution (6 ml) containing 0.9 M sodium chloride, 0.09 M Tris-hydrochloride buffer (pH 7.5), 0.006 M EDTA, 0.1 % Ficoll, 0.1% polyvinyl pyrrolidone (PVP), 0.1% bovine serum albumine (BSA), 0.5% SDS, 10% dextran sulfate and 100 µg/ml of E. coli DNA.
To the filter was added 2,500,000 cpm/ml of the product obtained by labelling 15 pmol of the previously synthesized oligonucleotide with (y-32P)ATP, and the filter was further left to stand at 37°C for 2 days. Then, the filter was washed with 0.9 M sodium-citrate, 0.9 M sodium chloride at 42°C three times each for 3 minutes, after which it was dried. Autoradiography of the dried product gave three strains which exhibited positive reactivity. The results of the autoradiography are shown in FIGS. 3A and 3B. A shows the whole result, and B shows a partially enlarged view thereof. The densely black dot in the figures is the mutant strain.

(5) Confirmation

The plasmid was taken out of the three strains obtained and hydrolyzed with the restriction endonuclease Hind III, whereby it was confirmed whether or not the restriction endonuclease recognition site was created. The plasmid was prepared by culturing the transformed strain in the presence of 25 pg/ml of ampicillin in 5 ml of L-medium to 0.4 OD/550 nm, and Spectinomycin was added to a final concentration of 300 µg/ml, after which the culture was left standing overnight. Of the cultured microorganism broth, 2 ml was collected and suspended by addition of 100 µl of a solution containing 2 mg/ml lysozyme, 50 mM glucose, 10 mM CDTA (1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid), and 25 mM Tris-hydrochloride buffer (pH 8.0), and the suspension was left to stand under ice-cooling for 30 minutes. Then, after centrifugation (5 minutes at 12,000 g), the supernatant was extracted with chloroform-phenol (1:1). Thereafter, 1 ml of ethanol was added to the aqueous layer, and the mixture was left to stand at -70°C for 5 minutes and further subjected to centrifugation (5 minutes at 12,000 g).
Confirmation of creation of the restriction endonuclease recognition site was performed by 1% Agarose gel electrophoresis, after ethanol precipitation was further repeated twice for the precipitate obtained, and the precipitate was hydrolyzed with Hind III. The result of the electrophoresis is shown in FIG. 4, in which A and B from the left side are those of the plasmid pYK 283, A being obtained by the reaction with Hind III and B being Control. C and D are those of the plasmid of the present invention, C being obtained by the reaction with EcoRI, D with Hind III, and E being Control.
Generally speaking, as the behavior of DNA on gel electrophoresis, treatment of ccc DNA (covalent closed circular DNA) with a restriction enzyme will make it a straight chain DNA, whereby its mobility becomes smaller. In FIG. 4, from A and B, it can be seen that there is no change in the band even by treatment of pYK 283 with the restriction endonuclease Hind III, indicating that there is no cleavage point for Hind III. On the other hand, from C (EcoRI treated), D (Hind III treated), and E (Control), it can be seen that the mobility of those subjected to treatment with restriction endonuclease (C, D) becomes greater, with the band appearing on the ⊖ side than Control (E). Thus, it can be seen that a new restriction endonuclease Hind III recognition site has been created. Also, the base sequence in the vicinity of the Hind III recognition site of this plasmid was confirmed according to the Maxam-Gilbert method (FIG. 5). The base sequence between (a) and (b) in the figure is GAATTCCCCAAGC-TTTTGTCA. In FIG. 5, the arrowheads (←) indicate the modified base sequence. Thus, it can be seen that, as shown by the two plasmids (pTA 529 and pYK 283) in 6 in FIG. 2, only the portion indicated by the arrowhead (↑) is changed, with the result that the restriction endonuclease Hind III recognition site (the portion encircled with the broken line) has been newly created.

Claims

1. A DNA (i) gene comprising a DNA (ii) portion corresponding to the gene coding for a signal peptide, said D_NA (ii) portion having one restriction endonuclease recognition site artificially created with at least one base pair of said DNA (ii) as at least a part of the members constituting said recognition site.

2. A DNA gene according to Claim 1, wherein no restriction endonuclease cleavage site within the restriction endonuclease site exists downstream from the boundary between said DNA (ii) portion corresponding to the gene coding for the signal peptide and a DNA (iii) portion which can exist linked to the downstream terminus of said DNA (ii) portion.

3. A DNA gene according to Claim 2, wherein the restriction endonuclease cleavage site exists at the boundary between said DNA (ii) portion corresponding to the gene coding for the signal peptide and said DNA (iii) portion which can exist linked to the downstream terminus of said DNA (ii) portion.

4. A DNA gene according to Claim 1, wherein the DNA (ii) corresponding to the gene coding for the signal peptide is one originated from a natural product.

5. A DNA gene according to Claim 1, wherein (1) the DNA (ii) portion corresponding to the gene coding for the signal peptide comprises a moiety upstream to the restriction endonuclease cleavage site within the restriction endonuclease recognition site artificially created, which is one originated from a natural product, and a moiety which can exist downstream from said restriction endonuclease cleavage site, which is synthesized, and (2) a DNA portion corresponding to the gene coding for an exogenous protein is contained immediately after the downstream terminus of the DNA (ii) portion corresponding to the gene coding for the signal peptide.

6. A DNA gene according to Claim 1, wherein the D_NA (ii) corresponding to the gene coding for the signal peptide originates from an alkaline phosphatase, the restriction endonuclease recognition site is the Hind III recognition site, and the restriction endonuclease cleavage site is located at the boundary between the DNA (ii) portion corresponding to the gene coding for the signal peptide and the DNA (iii) portion which can be linked directly to the downstream terminus of the DNA (ii) portion.

7. A process for producing a DNA (i) gene comprising a DNA (ii) portion corresponding to the gene coding for a signal peptide comprising the steps of:

(a) providing a DNA gene containing a D_NA portion (ii) corresponding to the gene coding for the signal peptide; and

(b) modifying the base sequence of the DNA (ii) portion without changing the amino acid sequence corresponding to said base sequence, thereby creating a restriction endonuclease recognition site containing, as at least a part thereof, at least one base pair of the DNA (ii) corresponding to the gene coding for the signal peptide.

8. A process according to Claim 7, wherein modification of the base sequence is accomplished by point mutation with the use of a synthetic fragment.

9. A process according to Claim 7, wherein the DNA (ii) gene comprising the DNA portion corresponding to the gene coding for the signal peptide originates form a natural product.

10. A process for producing a DNA (i) gene comprising a DNA (ii) portion corresponding to the gene coding for a signal peptide comprising the steps of:

(a) providing a DNA gene containing the DNA (ii) portion corresponding to the gene coding for the signal peptide;

(b) modifying the base sequence of the DNA (ii) portion without changing the amino acid sequence corresponding to said base sequence, thereby creating a restriction endonuclease recognition site containing, as at least a part thereof, at least one base pair of the DNA (ii) corresponding to the gene coding for the signal peptide;

(c) effecting cleavage at the restriction endonuclease cleavage site within the restriction endonuclease cleavage recognition site by the restriction endonuclease concerned, thereby producing a DNA (iv) fragment comprising a moiety upstream to the cleavage site of the DNA (ii) corresponding to the gene coding for the signal peptide and having cleaved end of said restriction endonuclease;

(d) providing a DNA fragment comprising a DNA (iii) which can exist downstream from the restriction endonuclease cleavage site of the DNA (ii) portion corresponding to the gene coding for the signal peptide and a DNA (v) corresponding to the gene coding for an exogenous protein existing directly downstream from the DNA (iii) which can exist, and having the restriction endonuclease cleaved end on the upstream terminus; and

(e) linking the DNA fragment from the above step (a) and the DNA fragment from the above step (d) to each other at the restriction endonuclease cleaved ends, thereby obtaining a DNA (i) gene comprising the DNA (ii) portion corresponding to the gene coding for the signal peptide and the DNA (v) portion corresponding to the gene coding for the exogenous protein directly linked to the downstream terminus of the DNA (ii) portion.

11. A process according to Claim 10, wherein modification of the base sequence is accomplished by point mutation with the use of a synthetic fragment.

12. A process according to Claim.10, wherein the DNA gene comprising the DNA (ii) portion corresponding to the gene coding for the signal peptide originates from a natural product.

13. A plasmid comprising a DNA portion corresponding to the controlling region derived from an alkaline phosphatase and a DNA (ii) portion corresponding to the gene coding for the signal peptide derived from the alkaline phosphatase, said DNA (ii) portion corresponding to the gene coding for the signal peptide being defined as follows:

(a) the DNA (ii) portion has a restriction endonuclease recognition site artificially created containing, as at least a part of said recognition site, at least one base pair thereof; and

(b) the restriction endonuclease cleavage site within said restriction endonuclease recognition site exists at the boundary between the DNA (ii) portion corresponding to the gene coding for the signal peptide and a DNA (iv) portion which is to exist linked directly to the downstream terminus of the DNA (ii) portion.

14. A plasmid pTA 529 according to Claim 12, wherein the codon (a) at the downstream terminus of the DNA (ii) portion corresponding to the gene coding for the signal peptide of the plasmid pYK 283 and the first codon (b) of the DNA directly linked to the codon (a) downstream therefrom are as shown in FIG. 1..